Busulfan and melphalan (Bu-Mel) versus carboplatin, etoposide, and melphalan (CEM) conditioning regimens for autologous haematopoietic stem cell transplant in children and young adults with high-risk neuroblastoma
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To compare the efficacy and safety of busulfan and melphalan (Bu-Mel) conditioning chemotherapy with carboplatin, etoposide, and melphalan (CEM) conditioning chemotherapy for autologous haematopoietic stem cell transplantation in children and young adults (0 to 21 years of age) with high-risk neuroblastoma.
Authors
- Jagdish Prasad Meena (ORCID: https://orcid.org/0000-0001-6024-9762)
- Shivam Bansal (ORCID: https://orcid.org/0000-0002-0630-6970)
- Sanjana Sarangarajan
- Aditya Gupta (ORCID: https://orcid.org/0000-0002-3730-8944)
- Mari Jeeva Sankar
- Manisha Komal
Institutions
- Children's Hospital at Westmead (AU)
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- Cochrane Database of Systematic Reviews
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1002/14651858.cd015131
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00